513 related articles for article (PubMed ID: 9032192)
21. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients.
Kharitonov SA; Yates DH; Barnes PJ
Am J Respir Crit Care Med; 1996 Jan; 153(1):454-7. PubMed ID: 8542158
[TBL] [Abstract][Full Text] [Related]
22. Topical steroid treatment of allergic rhinitis decreases nasal fluid TH2 cytokines, eosinophils, eosinophil cationic protein, and IgE but has no significant effect on IFN-gamma, IL-1beta, TNF-alpha, or neutrophils.
Benson M; Strannegård IL; Strannegård O; Wennergren G
J Allergy Clin Immunol; 2000 Aug; 106(2):307-12. PubMed ID: 10932075
[TBL] [Abstract][Full Text] [Related]
23. NO in exhaled air is correlated with markers of eosinophilic airway inflammation in corticosteroid-dependent childhood asthma.
Mattes J; Storm van's Gravesande K; Reining U; Alving K; Ihorst G; Henschen M; Kuehr J
Eur Respir J; 1999 Jun; 13(6):1391-5. PubMed ID: 10445617
[TBL] [Abstract][Full Text] [Related]
24. Short-term treatment with budesonide does not improve hyperresponsiveness to adenosine 5'-monophosphate in COPD.
Rutgers SR; Koëter GH; van der Mark TW; Postma DS
Am J Respir Crit Care Med; 1998 Mar; 157(3 Pt 1):880-6. PubMed ID: 9517606
[TBL] [Abstract][Full Text] [Related]
25. [Oral and inhaled corticoid therapy. Rivals or partners?].
Lacronique J
Rev Mal Respir; 1992; 9 Suppl 1():R69-71. PubMed ID: 1589633
[TBL] [Abstract][Full Text] [Related]
26. Neutrophilic inflammation in severe persistent asthma.
Jatakanon A; Uasuf C; Maziak W; Lim S; Chung KF; Barnes PJ
Am J Respir Crit Care Med; 1999 Nov; 160(5 Pt 1):1532-9. PubMed ID: 10556116
[TBL] [Abstract][Full Text] [Related]
27. [The small airway inflammation of asthmatic patients who have used dry powder type inhaled steroid for moderate-long term evaluated by induced sputum and the efficacy of HFA-BDP (QVAR) inhalation].
Ohbayashi H
Arerugi; 2005 Jan; 54(1):24-35. PubMed ID: 15841673
[TBL] [Abstract][Full Text] [Related]
28. Exhaled air molecular profiling in relation to inflammatory subtype and activity in COPD.
Fens N; de Nijs SB; Peters S; Dekker T; Knobel HH; Vink TJ; Willard NP; Zwinderman AH; Krouwels FH; Janssen HG; Lutter R; Sterk PJ
Eur Respir J; 2011 Dec; 38(6):1301-9. PubMed ID: 21700610
[TBL] [Abstract][Full Text] [Related]
29. Granulocyte function in the airways of allergen-challenged pigs: effects of inhaled and systemic budesonide.
Fornhem C; Peterson CG; Dahlbäck M; Scheynius A; Alving K
Clin Exp Allergy; 1996 Dec; 26(12):1436-48. PubMed ID: 9027445
[TBL] [Abstract][Full Text] [Related]
30. Inhaled budesonide aerosols in treatment of childhood asthma.
Phanichyakarn P; Wong EC
Asian Pac J Allergy Immunol; 1988 Dec; 6(2):111-5. PubMed ID: 3219157
[TBL] [Abstract][Full Text] [Related]
31. Additive effects of prednisolone and beclomethasone dipropionate in patients with stable chronic obstructive pulmonary disease.
Nishimura K; Ikeda A; Koyama H; Zhang M; Tsukino M; Hajiro T; Izumi T
Pulm Pharmacol Ther; 2000; 13(5):225-30. PubMed ID: 11001866
[TBL] [Abstract][Full Text] [Related]
32. Airway inflammation and cellular stress in noneosinophilic atopic asthma.
Tsoumakidou M; Papadopouli E; Tzanakis N; Siafakas NM
Chest; 2006 May; 129(5):1194-202. PubMed ID: 16685009
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the efficacy of ciclesonide 160 microg QD and budesonide 200 microg BID in adults with persistent asthma: a phase III, randomized, double-dummy, open-label study.
Niphadkar P; Jagannath K; Joshi JM; Awad N; Boss H; Hellbardt S; Gadgil DA
Clin Ther; 2005 Nov; 27(11):1752-63. PubMed ID: 16368446
[TBL] [Abstract][Full Text] [Related]
34. Withdrawal of corticosteroid therapy after acute asthma attacks.
CMAJ; 1995 Nov; 153(10):1471, 1473. PubMed ID: 7585376
[No Abstract] [Full Text] [Related]
35. Effects of different anti-asthmatic agents on induced sputum and eosinophil cationic protein in mild asthmatics.
Basyigit I; Yildiz F; Kacar Ozkara S; Boyaci H; Ilgazli A; Ozkarakas O
Respirology; 2004 Nov; 9(4):514-20. PubMed ID: 15612964
[TBL] [Abstract][Full Text] [Related]
36. [Place of inhaled corticoids in the treatment of asthma].
Rev Med Interne; 1992; 13(4):328. PubMed ID: 1287781
[No Abstract] [Full Text] [Related]
37. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients.
Ozol D; Aysan T; Solak ZA; Mogulkoc N; Veral A; Sebik F
Respir Med; 2005 Dec; 99(12):1494-500. PubMed ID: 15946834
[TBL] [Abstract][Full Text] [Related]
38. Changes in sputum eosinophils predict loss of asthma control.
Jatakanon A; Lim S; Barnes PJ
Am J Respir Crit Care Med; 2000 Jan; 161(1):64-72. PubMed ID: 10619799
[TBL] [Abstract][Full Text] [Related]
39. European Respiratory Society study on chronic obstructive pulmonary disease (EUROSCOP): hypothesis and design.
Pauwels RA; Löfdahl CG; Pride NB; Postma DS; Laitinen LA; Ohlsson SV
Eur Respir J; 1992 Nov; 5(10):1254-61. PubMed ID: 1486974
[TBL] [Abstract][Full Text] [Related]
40. Asymptomatic worsening of airway inflammation during low-dose allergen exposure in asthma: protection by inhaled steroids.
de Kluijver J; Evertse CE; Schrumpf JA; van der Veen H; Zwinderman AH; Hiemstra PS; Rabe KF; Sterk PJ
Am J Respir Crit Care Med; 2002 Aug; 166(3):294-300. PubMed ID: 12153960
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
